Incidence and Survival Among Young Women With Stage I–III Breast Cancer: SEER 2000–2015
Author(s) -
Alexandra Thomas,
Anthony Rhoads,
Elizabeth Pinkerton,
Mary C. Schroeder,
Kristin M. Conway,
W. Gregory Hundley,
Lacey R. McNally,
Jacob Oleson,
Charles F. Lynch,
Paul A. Romitti
Publication year - 2019
Publication title -
jnci cancer spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.345
H-Index - 10
ISSN - 2515-5091
DOI - 10.1093/jncics/pkz040
Subject(s) - medicine , breast cancer , incidence (geometry) , cancer , cancer registry , stage (stratigraphy) , epidemiology , oncology , gynecology , paleontology , physics , optics , biology
HR+ breast cancer is increasing in incidence among premenopausal women, and HR+ high-grade cancer was associated with reduced survival among women aged 20-29 years. Our findings can help guide further evaluation of preventive, diagnostic, and therapeutic strategies for breast cancer among premenopausal women.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom